Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

opella healthcare switzerland ag - retinoli palmitas, cholecalciferolum, rrr-alpha-tocopherolum, thiamini nitras, riboflavinum, pyridoxini hydrochloridum, cyanocobalaminum, biotinum, nicotinamidum, acidum ascorbicum, acidum folicum, cuprum, manganum, magnesium, ferrum, zincum, calcium, selenium, ginseng extractum siccum, lecithinum - capsula - vitamina: retinoli palmitas 2667 u.i., cholecalciferolum 200 u.i., rrr-alpha-tocopherolum 10 mg ut int-rac-alpha-tocopherylis acetas 14.9 mg, thiamini nitras 1.4 mg, riboflavinum 1.6 mg, pyridoxini hydrochloridum 2 mg, cyanocobalaminum 1 µg, biotinum 150 µg, nicotinamidum 18 mg, acidum ascorbicum 60 mg, acidum folicum 0.1 mg, mineralia: cupri sulfas corresp. cuprum 2 mg, mangani sulfas monohydricus corresp. manganum 2.5 mg, magnesii sulfas desiccatus corresp. magnesium 10 mg, ferrosi sulfas desiccatus corresp. ferrum 10 mg, zinci sulfas monohydricus corresp. zincum 1 mg, calcii hydrogenophosphas corresp. calcium 100 mg, natrii selenis desiccatus corresp. selenium 50 µg, alia: ginseng extractum siccum 40 mg corresp. ginsenosidea 1.6 mg, der: 3-7:1, auszugsmittel ethanol 38.6 % v/v, lecithinum 100 mg, rapae oleum raffinatum, adeps solidus, ethylvanillinum, gelatina, arachidis oleum raffinatum 1.16 mg, lactosum monohydricum 17.2-27.2 mg, silica colloidalis anhydrica, triglycerida media, e 320, e 321, e 307, kapselhülle: gelatina, glycerolum (85 per centum), e 172 (nigrum), e 172 (rubrum), pro capsula corresp. natrium 0.0295 mg. - la vitamina e mineralstoffpräparat in condizioni di carenza di età - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - retinoli palmitas, thiamini hydrochloridum, riboflavinum, nicotinamidum, acidum pantothenicum, pyridoxini hydrochloridum, biotinum, acidum folicum, cyanocobalaminum, acidum ascorbicum, cholecalciferolum, rrr-alpha-tocopherolum, ginseng extractum siccum, calcium, magnesium, ferrum, zincum, cuprum, iodum, manganum, selenium - compresse rivestite con film - retinoli palmitas 1333 u.i., thiamini hydrochloridum 2.1 mg ut thiamini nitras 2.04 mg, riboflavinum 2.4 mg, nicotinamidum 18 mg, acidum pantothenicum 6 mg ut calcii pantothenas 6.52 mg, pyridoxini hydrochloridum 3 mg, biotinum 75 µg, acidum folicum 0.3 mg, cyanocobalaminum 1.5 µg, acidum ascorbicum 90 mg ut calcii ascorbas 108.9 mg, cholecalciferolum 200 u.i., rrr-alpha-tocopherolum 15 mg ut int-rac-alpha-tocopherylis acetas 22.38 mg, ginseng extractum siccum 50 mg, calcium 160 mg ut calcii carbonas 369.96 mg et calcii ascorbas et calcii pantothenas, magnesium 120 mg ut magnesii oxidum ponderosum 198.32 mg et magnesii stearas 10 mg, ferrum 5.6 mg ut ferrosi fumaras 17.04 mg, zincum 6 mg ut zinci citras trihydricus 19.22 mg, cuprum 1 mg ut cupri sulfas 2.51 mg, iodum 60 µg ut kalii iodidum 80.5 µg, manganum 1.4 mg ut mangani sulfas monohydricus 4.31 mg, selenium 28 µg ut natrii selenis 60 µg, povidonum k 30, gelatina, carmellosum natricum conexum, mannitolum, macrogolum 6000, lactosum 220.6 mg, hypromellosum, hydroxypropylcellulosum, talcum, titanii dioxidum, e 141, saccharum 1.95 mg, maydis amylum, natrii ascorbas, triglycerida media, silica colloidalis anhydrica, amylum modificatum, e 1450, glucosum liquidum dispersione desiccatum max. 10.95 mg pro compresso obducto corresp. natrium 0.94 mg. - la vitamina e mineralstoffpräparat - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - retinoli palmitas, thiamini hydrochloridum, riboflavinum, nicotinamidum, acidum pantothenicum, pyridoxini hydrochloridum, biotinum, acidum folicum, cyanocobalaminum, acidum ascorbicum, cholecalciferolum, rrr-alpha-tocopherolum, ginseng extractum siccum, calcium, magnesium, cuprum, iodum, ferrum, manganum, selenium, zincum - compresse effervescenti - retinoli palmitas 1333 u.i., thiamini hydrochloridum 2.1 mg ut monophosphothiamini chloridum, riboflavinum 2.4 mg ut riboflavini natrii phosphas, nicotinamidum 18 mg, acidum pantothenicum 6 mg ut calcii pantothenas, pyridoxini hydrochloridum 3 mg, biotinum 75 µg, acidum folicum 300 µg, cyanocobalaminum 1.5 µg, acidum ascorbicum 90 mg, cholecalciferolum 200 u.i., rrr-alpha-tocopherolum 15 mg ut int-rac-alpha-tocopherylis acetas, ginseng extractum siccum 50 mg, calcium 160 mg ut calcii carbonas et calcii glycerophosphas et calcii pantothenas, magnesium 120 mg ut magnesii hydrogenophosphas trihydricus et magnesii oxidum ponderosum, cuprum 1 mg ut cupri(ii) d-gluconas, iodum 60 µg ut kalii iodidum, ferrum 5.6 mg ut ferrosi lactas dihydricus, manganum 1.4 mg ut mangani sulfas monohydricus, selenium 28 µg ut natrii selenis, zincum 6 mg ut zinci citras trihydricus, acidum citricum, natrii hydrogenocarbonas, natrii carbonas, maltitolum 168.56 mg, sorbitolum 353.92 mg, povidonum k 30, polysorbatum 60, crospovidonum, mannitolum, polysorbatum 80, simeticonum, sacchari monopalmitas, e 162, e 160(a), cocois oleum, maltodextrinum, acaciae gummi, saccharum 7.27-9.02 mg, e 301, silica colloidalis anhydrica, e 307, natrii chloridum, aspartamum 40 mg, acesulfamum kalicum, aromatica (orange), aromatica (passionsfrucht), natrii citras dihydricus, gelatina, maydis amylum, sojae oleum partim hydrogenatum 0.18 mg, amylum modificatum, pro compresso corresp. natrium 227 mg. - la vitamina e mineralstoffpräparat - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

mylan pharmaceuticals limited - prasugrel besilate - myocardial infarction; acute coronary syndrome; angina, unstable - agenti antitrombotici - prasugrel mylan, co somministrato con acido acetilsalicilico (asa), è indicato per la prevenzione di eventi atherothrombotic in pazienti adulti con sindrome coronarica acuta (mi. angina instabile, segmento non-st-elevation infarto miocardico [ua/ggt] o segmento st elevation infarto miocardico [stemi]) in fase di primario o ritardato intervento coronarico percutaneo (pci).

Unione Europea - italiano - EMA (European Medicines Agency)

xbiotech germany gmbh - anticorpo monoclonale umano igg1 specifico per l'interleuchina-1 alfa umana - neoplasie colorettali - agenti antineoplastici - trattamento del cancro colorettale metastatico.

Unione Europea - italiano - EMA (European Medicines Agency)

laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - pigs - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.

Italia - italiano - Ministero della Salute

saviopharma italia - flaconcini - acido r(+) alfa-lipoico - invecchiamento e stress ossidativo

Unione Europea - italiano - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leucemia, mieloide - agenti antineoplastici - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.

Italia - italiano - Ministero della Salute

ge hungary zrt. healthcare - mammografi convenzionali

Italia - italiano - Ministero della Salute

ge hungary zrt. healthcare - mammografi convenzionali